19 results
8-K
EX-10.1
EVLO
Evelo Biosciences, Inc.
12 Jul 23
Evelo Biosciences Closes $25.5 Million Private Placement
7:55am
counsel, a conflict of interest exists between such person and the indemnifying party with respect to such claims (in which case, if the person notifies
PRE 14A
EVLO
Evelo Biosciences, Inc.
18 Apr 23
Preliminary proxy
5:24pm
, following his appointment as Global Head of Global Drug Discovery at AbbVie, Inc. (“AbbVie”), to avoid the potential for a conflict of interest … $120,000. The compensation committee evaluated whether any of the work performed by Pay Governance during 2022 raised any conflict of interest
8-K
EVLO
Evelo Biosciences, Inc.
5 Apr 22
Departure of Directors or Certain Officers
5:22pm
Drug Discovery at AbbVie, Inc. (“AbbVie”), to avoid the potential for a conflict of interest arising from similarities in the Company's and Abbvie’s
8-K
EX-3.1
rww bgi256xqua
18 Mar 21
Amendments to Articles of Incorporation or Bylaws
4:45pm
8-K
onwsdg5yl0i09h8 uy
28 Feb 20
Departure of Directors or Certain Officers
4:00pm
8-K
EX-10.2
mogm9l4x cj5f
18 Sep 19
Departure of Directors or Certain Officers
4:41pm
8-K
EX-10.1
jufe8i1ug66
24 Jul 19
Entry into a Material Definitive Agreement
4:19pm
DEF 14A
841wzlrwgf8q3
25 Apr 19
Definitive proxy
5:21pm
10-K
EX-10.12
omkom 507lwq759j
15 Feb 19
Annual report
4:20pm
8-K
EX-3.2
nc3au6uytc
11 May 18
Amendments to Articles of Incorporation or Bylaws
4:16pm
S-8
EX-4.4
t31wlfh44i tl
10 May 18
Registration of securities for employees
5:15pm
S-1/A
EX-3.4
0v5c9vd862oqi6q4oi
30 Apr 18
IPO registration (amended)
6:22am
S-1/A
EX-10.6
loatl8 069f
30 Apr 18
IPO registration (amended)
6:22am
- Prev
- 1
- Next